HDM201 and Midostaurin (HDMM) in Relapsed/Refractory AML With FLT3mut and TP53wt.
Clinical trial NCT04496999 · TERMINATED
Trial details
- NCT number
- NCT04496999
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2022-09-09
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.